Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 09 tags : Pharm-country save search
Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
ORMP A | $2.35 0.86% 2.51% 31K
|
Health Technology
|
| O: -0.79%
H: 8.26%
C: 5.03%
conference
PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
PDSB | $3.2 7.02% 6.56% 990K
|
Health Technology
|
| O: 0.59%
H: 6.23%
C: 1.56%
phase 2 cancer biotech iot trial keytruda enroll
Biohaven Spotlights Nurtec® ODT (rimegepant), the only dual-therapy indicated for both the acute and preventive treatment of migraine, at the 2021 International Headache Society - European Headache Federation Joint Congress
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
BHVN | News 0 d | $39.61 3.34% 6.03% 1.9M
|
Health Technology
|
| O: -0.14%
H: 2.85%
C: -0.58%
treatment europe migraine therapy
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
SNGX | $0.4 -1.43% -1.15% 410K
|
Health Technology
|
| O: 12.38%
H: 4.24%
C: -1.69%
treatment fda drug t-cell granted grant designation
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.